Last $42.24 USD
Change Today -0.11 / -0.26%
Volume 4.4M
ABT On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
London
Sao Paulo
Frankfurt
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

abbott laboratories (ABT) Snapshot

Open
$42.41
Previous Close
$42.35
Day High
$42.41
Day Low
$42.06
52 Week High
07/23/14 - $43.27
52 Week Low
09/3/13 - $32.70
Market Cap
63.5B
Average Volume 10 Days
3.2M
EPS TTM
$1.95
Shares Outstanding
1.5B
EX-Date
07/11/14
P/E TM
21.7x
Dividend
$0.88
Dividend Yield
1.89%
Current Stock Chart for ABBOTT LABORATORIES (ABT)

abbott laboratories (ABT) Details

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as various forms of prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. Abbott Laboratories also offers blood glucose and glucose monitoring systems, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, such as cataract surgery, LASIK surgery, and contact lens care and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. It has strategic alliance with Fonterra Co-operative Group Ltd. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.

69,000 Employees
Last Reported Date: 02/21/14
Founded in 1888

abbott laboratories (ABT) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.9M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $969.7K
Executive Vice President, General Counsel and...
Total Annual Compensation: $650.0K
Executive Vice President of Diagnostic Produc...
Total Annual Compensation: $614.6K
Executive Vice President of Corporate Develop...
Total Annual Compensation: $629.5K
Compensation as of Fiscal Year 2013.

abbott laboratories (ABT) Key Developments

BioView Ltd. Expands its Connections with Abbot Laboratories

BioView Ltd. is expanding its connections with Abbot Laboratories. BioView notified the TASE that it had signed a cooperation agreement with Abbot for development purposes. Under the current agreement, Abbot is slated to develop signs using Fish technology, which can identify an excess or lack of certain genes in a cell, and detect whether a certain gene is playing a role in the development of diseases, for research and testing purposes. BioView will develop imaging software for these markers. Each side will bear its own costs - Abbot for developing the sign, and BioView for developing the software. BioView said in its announcement that the products resulting from this joint development would be marketed and distributed by Abbot under the distribution agreement between the two companies. Under the distribution agreement signed in June 2013, Abbot is the global distributor for the Duet systems being developed by BioView. These systems perform automatic scanning, diagnosis, and control of biological samples. The agreement gives Abbot exclusive worldwide distribution rights to BioView's products, excluding the US and Canada, where exclusivity is not granted. Marketing by Abbot in the US and Canada takes place simultaneously with direct distribution by BioView and its partners.

Abbott Joins with U.S. Department of Defense to Develop Portable Blood Tests for Evaluating Concussions

Abbott and the United States Department of Defense announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain injuries (TBIs). As part of a multi-phased approach, the tests would be developed for Abbott's i-STAT(R) System, a handheld, diagnostic analyzer that is currently used for other point-of-care testing, including among military service members. Concussions are a significant health concern for military service members. With the development of new tests, physicians could use the information to positively impact the care of people with a suspected concussion.

McKenzie Lake Lawyers, LLP and Morganti Legal, P.C. File Class Action Lawsuit Against Abbott Laboratories, Abbott Products, Abbott Products Canada, and Abbvie Products LLC

McKenzie Lake Lawyers, LLP and Morganti Legal, P.C. have filed a class action lawsuit against Abbott Laboratories Ltd., Abbott Products Inc., Abbott Products Canada Inc., and Abbvie Products LLC, the makers and sellers of Androgel on June 26, 2014. The Androgel Claim alleges that Abbott knew or should have known of these risks and failed to warn the public. The lawsuit also claims Abbott aggressively marketed Androgel by misleading potential users about the prevalence and symptoms of low testosterone, along with the safety and efficacy of Androgel treatment, ultimately failing to protect users from serious, life-threatening, adverse medical events.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $42.24 USD -0.11

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $55.28 USD -0.32
Actavis plc $226.98 USD +0.39
Danaher Corp $76.61 USD +0.28
Medtronic Inc $63.85 USD +0.73
Teva Pharmaceutical Industries Ltd $52.52 USD +0.42
View Industry Companies
 

Industry Analysis

ABT

Industry Average

Valuation ABT Industry Range
Price/Earnings 30.5x
Price/Sales 2.9x
Price/Book 2.7x
Price/Cash Flow 20.3x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit www.abbott.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.